The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Dr. John Hays on Gynecologic Cancer Mutations and Choosing the Right Treatment

John Hays, MD
Published Online:7:38 AM, Tue March 22, 2016

John Hays, MD, assistant professor, Internal Medicine, College of Medicine, Ohio State University, discusses the plethora of genetic mutation information oncologists have when it comes to treating gynecologic cancers. Hays says current genetic testing gives oncologists a wide variety of information that may make choosing the correct treatment "a little more difficult." Hays adds that within the current treatment paradigm of gynecologic cancer, oncologists are mainly focusing on BRCA mutations.

Hays says as new genetic mutations are being discovered, treatments to target those mutations are also being developed. He says one of the major difficulties with coming up with new treatments for these genetic mutations are that the mutation rates are low.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.